Extracorporeal membrane oxygenation in life-threatening ANCA-positive diffuse necrotizing alveolar hemorrhage


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Pulmonary pathology in microscopic polyangiitis (MPa) is diagnosed in 25-70% of cases and is primarily represented by necrotizing hemorrhagic alveolitis, which can be the initial manifestation of an autoimmune disease and is a life-threatening pathology requiring the clinician to immediately diagnose and promptly assign adequate pathogenetic therapy. a case of fatal hemorrhagic pneumonitis with pulmonary hemorrhage and rapidly progressive glomerulonephritis due to MPa is presented. According to the ineffectiveness of the artificial lung ventilation, the patient had required the extracorporeal membrane oxygenation, that had improved the respiratory function of the lungs until the development of clinical effectiveness of pathogenetic therapy of MPa, including high-volume plasma exchange, high doses of corticosteroids, immunoglobulins and cytostatics.

全文:

受限制的访问

作者简介

M. Lysenko

SBCHI "City Clinical Hospital № 52 of the Moscow Healthcare Department"

Doctor of Medical Sciences, Chief Physician

N. Frolova

SBCHI "City Clinical Hospital № 52 of the Moscow Healthcare Department"

PhD in Medical Science, Head of the 2-nd Nephrological Department, Nephrologist

M. Ketskalo

SBCHI "City Clinical Hospital № 52 of the Moscow Healthcare Department"

PhD in Medical Science, Anesthesiologist-Reanimatologist, Head of the Center for Extracorporeal Membrane Oxygenation

E. Dyakova

SBCHI "City Clinical Hospital № 52 of the Moscow Healthcare Department"

Nephrologist at the 2nd Nephrological Department

I. Sysoeva

SBCHI "City Clinical Hospital № 52 of the Moscow Healthcare Department"

Nephrologist at the 2nd Nephrological Department

T. Zhilinskaya

SBCHI "City Clinical Hospital № 52 of the Moscow Healthcare Department"

Nephrologist at the Consultative and Diagnostic Nephrological Department

O. Kotenko

SBCHI "City Clinical Hospital № 52 of the Moscow Healthcare Department"; FSAEI HE PFUR

Email: olkotenko@yandex.ru
PhD in Medical Science, Chief Freelance Nephrologist at the Moscow Healthcare Department, Deputy Chief Physician for Nephrology; Associate Professor at the Department of Hospital Therapy with the Course of Hematology

G. Volgina

FAPE GSBEI HE. A.I. Yevdokimov MSMSU of the Mistry of Health of the Russian Federation

Email: Volginagv@mail.ru
Doctor of Medical Sciences, Prof. at the Department of Nephrology

参考

  1. Chen H., Yu R.G., Yin N.N., Zhou J.X. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review. Crit. Care. 2014;18(6):675.
  2. Gуmez-Puerta J.A., Hernndez-Rodmguez J., Lypez-Soto A., Bosch X. Antineutrophil cytoplasmic antibody-associated vasculitides and respiratory disease. Chest. 2009;136:1101-11.
  3. Cordier J.F, Cottin V. Alveolar haemorrhage in vasculitis: primary and secondary. Semin. Respir. Crit. Care Med. 2011;32:310-321.
  4. Cartin-Ceba R., Diaz-Caballero L., Al-Qadi M.O., Tryfon S., Fervenza F.C., Ytterberg S.R., Specks U. Diffuse alveolar hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: predictors of respiratory failure and clinical outcomes.Arthritis Rheumatol. 2016; 68:1467-1476.
  5. Hruskova Z., Casian A.L., Konopasek P., Svobodova B., Frausova D., Lanska V., Tesar V., Jayne D.R. Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study. Scand. J. Rheumatol. 2013;42:211-214.
  6. Guillevin L., Pagnoux C., Seror R., Mahr A., Mouthon L., Le Toumelin P. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine. 2011;90:19-27.
  7. Griffith M., Brett S. The pulmonary physician in critical care - illustrative case 3: pulmonary vasculitis. Thorax. 2003;58:543-546.
  8. Sugimoto T., Deji N., Kume S., Osawa N., Sakaguchi M., Isshiki K., Koya D., Kashiwagi A. Pulmonary-renal syndrome, diffuse pulmonary haemorrhage and glomerulonephritis, associated with Wegener’s granulomatosis effectively treated with early plasma exchange therapy. Intern Med. 2007; 46:49-53.
  9. Raoof S., Goulet K., Esan A., Hess D.R., Sessler C.N. Severe hypoxemic respiratory failure: part 2: nonventilatory strategies. Chest. 2010; 137:1437-1448.
  10. MacLaren G., Combes A., Bartlett R.H. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Med. 2012;38:210-220.
  11. Combes A., Bacchetta М., Brodie D., Müller T., Pellegrino V. Extracorporeal membrane oxygenation for respiratory failure in adults. Curr. Opin. Crit. Care. 2012;18:99-114.
  12. Malgon I., Greenhalgh D. Extracorporeal membrane oxygenation as an alternative to ventilation. Curr. Opin. Anaesthesiol. 2013;26:47-52.
  13. Butt W., Mac Laren G. Extracorporeal membrane oxygenation. Prime Reports. 2013;5:55-61.
  14. Lango R., Szkulmowski Z., Maciejewski D., Sosnowski А., Kusza К. Revised protocol of extracorporeal membrane oxygenation (ECMO) therapy in severe ARDS. Recommendations of the Veno-venous ECMO Expert Panel appointed in February 2016 by the national consultant on anesthesiology and intensive care. Anaesthesiology Intensive Therapy. 2017;49(2):88-99.
  15. Lee J.J., Hwang S.M., Ко J.H., Kim H.S., Hong K.S., Choi H.H., Lee M.G., Lee C.Y., Lee W.K., Soun E.J., Lee T.H., Seo J.Y. Efficacy of veno-venous extracorporeal membrane oxygenation in severe acute respiratoryfailure. Yonsei Med. J. 2015;56(1):212-219. doi: 10.3349/ymj.2015.56.1.212.
  16. Lawson W.E., Koo M. Percutaneous Ventricular Assist Devices and ECMO in the Management of Acute Decompensated Heart Failure. Clin. Med. Insights Cardiol 2015; 9(1):41-48. doi: 10.4137/CMC.S19701.
  17. Schmidt M., Bailey M., Sheldrake J., Hodgson C., Aubron C., Rycus P.T., Scheinkestel C., Cooper D.J., Brodie D., Pellegrino V., Combes A., Pilcher D. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am.J. Respir. Crit. Care Med. 2014;189:1374-1382. doi: 10.1164/rccm.201311-2023OC.
  18. Tulman D.B., Stawicki S.P, Whitson B.A., Gupta S.C., Tripathi R.S., Firstenberg M.S., Hayes D.Jr., Xu X., Papadimos T.J. Veno-venous ECMO: a synopsis of nine key potential challenges, considerations, and controversies. BMC Anesthesiol. 2014;14:65. doi: 10.1186/1471-2253-14-65.
  19. Tramm R., Ilic D., Davies A.R., Pellegrino V.A., Romero L., Hodgson C. Extracorporeal membrane oxygenationfor critically ill adults//Cochrane Database Syst. Rev. 2015;1:CD010381. doi: 10.1002/14651858.CD010381.pub2.
  20. Mishra V., Svennevig J.L., Bugge J.F., Andresen S., Mathisen A., Karlsen H., Khushi I., Hagen T.P Cost of extracorporeal membrane oxygenation: evidence from the Riks hospitalet University Hospital, Oslo, Norway. Eur. J. Cardiothorac. Surg. 2010; 37:339-342. doi: 10.1016/j.ejcts.2009.06.059.
  21. Peek G.J., Mugford M., Tiruvoipati R. Wilson A., Allen E., Thalanany M.M., Hibbert C.L., Truesdale A., Clemens F., Cooper N., Firmin R.K., Elbourne D. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet. 2009;374:1351-1363. doi: 10.1016/S0140-6736(09)61069-2.
  22. Aghili N., KangS., Kapur N.K. The fundamentals of extra-corporeal membrane oxygenation. Minerva Cardioangiol. 2015;63(1):75-85.
  23. Cordier J.F., Cottin V Alveolar haemorrhage in vasculitis: primary and secondary. Semin. Respir. Crit. Care Med. 2011;32:310-321. doi: 10.1055/s-0031-1279827.
  24. Kumesh L., Harper L., Savage C.O. ANCA-positive Vasculitis. J. Am. Soc. Nephrol. 2002;13:1953-1960.
  25. Rabe C., Appenrodt B., Hoff C., Ewig S., Klehr H.U., Sauerbruch T. et al. Severe respiratory failure due to diffuse alveolar hemorrhage: Clinical characteristics and outcome of intensive care. Journal of Critical Care. 2010;25:230-235. doi: 10.1016/j.jcrc.2009.04.009.
  26. Hohenforst-Schmidt W, Petermann A., Visouli A., Zarogoulidis P., Darwiche K., Kougioumtzi I. et al. Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitis. Drug Des. Devel. Ther. 2013;7:627-633. doi: 10.2147/DDDT. S47156.
  27. Krause M.L., Cartin-Ceba R., Specks U., Peikert T. Update on diffuse alveolar hemorrhage and pulmonary vasculitis. Immunol. Allergy Clin. North Am. 2012;32(4):587-600. doi: 10.2147/DDDT.S47156.
  28. Malgon I., Greenhalgh D. Extracorporeal membrane oxygenation as an alternative to ventilation. Curr. Opin. Anaesthesiol. 2013; 26:47-52. doi: 10.1097/ACO.0b013e32835bf1be.
  29. Yusuff H., Malagon I., Robson K., Parmar J., Hamilton P., Falter F. Extracorporeal membrane oxygenation for Life-threatening ANCA-positive pulmonary capillaritis. A review of UK experience. Heart Lung Vessel. 2015;7(2):159-167.
  30. Hohenforst-Schmidt W., Petermann A., Visouli A. Zarogoulidis P., Darwiche K., Kougioumtzi I., Tsakiridis K., Machairiotis N., Ketteler M., Zarogoulidis K., Brachmann J. Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitis. Drug Des. Devel.Ther. 2013;7:627-633. doi: 10.2147/DDDT.S47156.
  31. Keller R., Torres S., Iölster T., Kreutzer C., Fraire R., Grassi M., Arrese D., Trabadelo O., Rocca Rivarola M. Extracorporeal membrane oxygenation and plasmapheresis in the treatment of severe pulmonary hemorrhage secondary to nodose polyarteritis. Arch. Argent Pediatr. 2012;110(4):e80-85.
  32. Barnes S.L., Naughton M., Douglass J., Murphy D. Extracorporeal membrane oxygenation with plasma exchange in a patient with alveolar haemorrhage secondary to Wegener’s granulomatosis. Intern. Med. J. 2012;42(3):341-342.
  33. Joseph M., Charles A.G. Early extracorporeal life support as rescue for Wegener granulomatosis with diffuse alveolar hemorrhage and acute respiratory distress syndrome: a case report and literature review. Pediatr. Emerg. Care. 2011;27(12):1163-1166.
  34. Yates M., Watts R.A., Bajema I.M., et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann. Rheum. Dis. 2016;75:1583-1594. doi: 10.1136/annrheumdis-2016-209133.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##